TY - JOUR
T1 - Extracranial soft-tissue tumors
T2 - Repeatability of apparent diffusion coefficient estimates from diffusion-weighted MR imaging
AU - Winfield, Jessica M.
AU - Tunariu, Nina
AU - Rata, Mihaela
AU - Miyazaki, Keiko
AU - Jerome, Neil P.
AU - Germuska, Michael
AU - Blackledge, Matthew D.
AU - Collins, David J.
AU - De Bono, Johann S.
AU - Yap, Timothy A.
AU - DeSouza, Nandita M.
AU - Doran, Simon J.
AU - Koh, Dow Mu
AU - Leach, Martin O.
AU - Messiou, Christina
AU - Orton, Matthew R.
N1 - Funding Information:
Supported by Cancer Research UK and Engineering and Physical Sciences Research Council support to the Cancer Imaging Centre at the Institute of Cancer Research and Royal Marsden Hospital in association with the Medical Research Council and Department of Health C1060/A10334, C1060/A16464 and National Health Service funding to the National Institute for Health Research (NIHR) Biomedical Research Centre and the Clinical Research Facility in Imaging. M.O.L. is an Emeritus NIHR Senior Investigator.
Publisher Copyright:
© 2017 RSNA.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Purpose: To assess the repeatability of apparent diffusion coefficient (ADC) estimates in extracranial soft-tissue diffusionweighted magnetic resonance imaging across a wide range of imaging protocols and patient populations. Materials and Methods: Nine prospective patient studies and one prospective volunteer study, performed between 2006 and 2016 with research ethics committee approval and written informed consent from each subject, were included in this singleinstitution study. A total of 141 tumors and healthy organs were imaged twice (interval between repeated examinations, 45 minutes to 10 days, depending the on study) to assess the repeatability of median and mean ADC estimates. The Levene test was used to determine whether ADC repeatability differed between studies. The Pearson linear correlation coefficient was used to assess correlation between coefficient of variation (CoV) and the year the study started, study size, and volumes of tumors and healthy organs. The repeatability of ADC estimates from small, medium, and large tumors and healthy organs was assessed irrespective of study, and the Levene test was used to determine whether ADC repeatability differed between these groups. Results: CoV aggregated across all studies was 4.1% (range for each study, 1.7%-6.5%). No correlation was observed between CoV and the year the study started or study size. CoV was weakly correlated with volume (r = 20.5, P = .1). Repeatability was significantly different between small, medium, and large tumors (P < .05), with the lowest CoV (2.6%) for large tumors. There was a significant difference in repeatability between studies-a difference that did not persist after the study with the largest tumors was excluded. Conclusion: ADC is a robust imaging metric with excellent repeatability in extracranial soft tissues across a wide range of tumor sites, sizes, patient populations, and imaging protocol variations.
AB - Purpose: To assess the repeatability of apparent diffusion coefficient (ADC) estimates in extracranial soft-tissue diffusionweighted magnetic resonance imaging across a wide range of imaging protocols and patient populations. Materials and Methods: Nine prospective patient studies and one prospective volunteer study, performed between 2006 and 2016 with research ethics committee approval and written informed consent from each subject, were included in this singleinstitution study. A total of 141 tumors and healthy organs were imaged twice (interval between repeated examinations, 45 minutes to 10 days, depending the on study) to assess the repeatability of median and mean ADC estimates. The Levene test was used to determine whether ADC repeatability differed between studies. The Pearson linear correlation coefficient was used to assess correlation between coefficient of variation (CoV) and the year the study started, study size, and volumes of tumors and healthy organs. The repeatability of ADC estimates from small, medium, and large tumors and healthy organs was assessed irrespective of study, and the Levene test was used to determine whether ADC repeatability differed between these groups. Results: CoV aggregated across all studies was 4.1% (range for each study, 1.7%-6.5%). No correlation was observed between CoV and the year the study started or study size. CoV was weakly correlated with volume (r = 20.5, P = .1). Repeatability was significantly different between small, medium, and large tumors (P < .05), with the lowest CoV (2.6%) for large tumors. There was a significant difference in repeatability between studies-a difference that did not persist after the study with the largest tumors was excluded. Conclusion: ADC is a robust imaging metric with excellent repeatability in extracranial soft tissues across a wide range of tumor sites, sizes, patient populations, and imaging protocol variations.
UR - http://www.scopus.com/inward/record.url?scp=85021063123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021063123&partnerID=8YFLogxK
U2 - 10.1148/radiol.2017161965
DO - 10.1148/radiol.2017161965
M3 - Article
C2 - 28301311
AN - SCOPUS:85021063123
SN - 0033-8419
VL - 284
SP - 88
EP - 99
JO - Radiology
JF - Radiology
IS - 1
ER -